Canopy Growth Corp Gains Losses On Fair Value Adjustment Attributable To Price Changes Biological Assets
Canopy Growth Corp (CGC) reported Gains Losses On Fair Value Adjustment Attributable To Price Changes Biological Assets of CAD 8.43 million for the 12-month period ending 2018-03-31, per its 40-F filed 2018-06-28.
Discontinued › Income Statement › Other Income
ifrs-full:GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets · last filed 2018-06-28
| Period end | Gains Losses On Fair Value Adjustment Attributable To Price Changes Biological Assets 12 month |
|---|---|
| 2018-03-31 | 8.43M CAD 40-F · filed 2018-06-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |